BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other ...
On the heels of a comprehensive review, BioNTech has decided “to close its planned Singapore site by the end of February 2027 ...
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver ...
Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by Pfizer (PFE) and BioNTech (BNTX), marking the latest such case among ...
Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.
Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...
By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
Pfizer Inc PFE and its German COVID-19 vaccine partner BioNTech SE BNTX have reportedly halted recruitment for a large U.S.
24/7 Wall St. on MSN
3 companies built their fortunes on COVID vaccines, but only 1 has a real plan for what comes next
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast. Moderna (NASDAQ: MRNA) has fallen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results